Adelaide Cancer Centre, Kurralta Park, South Australia, Australia.
Intern Med J. 2012 Jun;42(6):698-708. doi: 10.1111/j.1445-5994.2012.02808.x.
Each year in Australia, about 1 in 1000 people develop a first episode of venous thromboembolism (VTE), which approximates to about 20,000 cases. More than half of these episodes occur during or soon after a hospital admission, which makes them potentially preventable. This paper summarises recommendations from the National Health and Medical Research Council's 'Clinical Practice Guideline for the Prevention of Venous Thromboembolism in Patients Admitted to Australian Hospitals' and describes the way these recommendations were developed. The guideline has two aims: to provide advice on VTE prevention to Australian clinicians and to support implementation of effective programmes for VTE prevention in Australian hospitals by offering evidence-based recommendations which local hospital guidelines can be based on. Methods for preventing VTE are pharmacological and/or mechanical, and they require appropriate timing, dosing and duration and also need to be accompanied by good clinical care, such as promoting mobility and hydration whilst in hospital. With some procedures or injuries, the risk of VTE is sufficiently high to require that all patients receive an effective form of prophylaxis unless this is contraindicated; in other clinical settings, the need for prophylaxis requires individual assessment. For optimal VTE prevention, all patients admitted to hospital should have early and formal assessments of: (i) their intrinsic VTE risk and the risks related to their medical conditions; (ii) the added VTE risks resulting from surgery or trauma; (iii) bleeding risks that would contraindicate pharmacological prophylaxis; (iv) any contraindications to mechanical prophylaxis, culminating in (v) a decision about prophylaxis (pharmacological and/or mechanical, or none). The most appropriate form of prophylaxis will depend on the type of surgery, medical condition and patient characteristics. Recommendations for various clinical circumstances are provided as summary tables with relevance to orthopaedic surgical procedures, other types of surgery and medical inpatients. In addition, the tables indicate the grades of supporting evidence for the recommendations (these range from Grade A which can be trusted to guide practice, to Grade D where there is more uncertainty; Good Practice Points are consensus-based expert opinions).
在澳大利亚,每年大约有 1/1000 的人会首次出现静脉血栓栓塞症(venous thromboembolism,VTE),大约有 20000 例。其中一半以上的发作发生在住院期间或住院后不久,这使得它们具有潜在的可预防性质。本文总结了澳大利亚国家卫生和医学研究委员会(National Health and Medical Research Council)“澳大利亚住院患者静脉血栓栓塞症预防临床实践指南”中的建议,并描述了这些建议的制定方式。该指南有两个目标:向澳大利亚临床医生提供关于 VTE 预防的建议,并通过提供基于当地医院指南的循证建议,为澳大利亚医院的 VTE 预防提供有效的项目支持。预防 VTE 的方法有药物和/或机械两种,需要合适的时机、剂量和持续时间,并且需要配合良好的临床护理,如在住院期间促进活动和补液。对于某些手术或损伤,VTE 的风险足够高,需要所有患者接受有效的预防措施,除非有禁忌证;在其他临床环境中,需要根据个体情况评估预防的必要性。为了实现最佳的 VTE 预防,所有住院患者都应接受以下方面的早期和正式评估:(i)他们的固有 VTE 风险以及与他们的医疗状况相关的风险;(ii)手术或创伤引起的额外 VTE 风险;(iii)药物预防的出血风险禁忌证;(iv)机械预防的任何禁忌证,最终(v)做出预防(药物和/或机械,或不预防)决策。最适当的预防形式将取决于手术类型、医疗状况和患者特征。针对各种临床情况的建议以概要表的形式呈现,涉及骨科手术、其他类型的手术和内科住院患者。此外,这些表格还表明了建议的证据支持等级(从可信赖指导实践的 A 级到不确定性较高的 D 级不等;良好实践要点是基于共识的专家意见)。